Navigation Links
Researchers collaborate to find new vaccine technology decreases E. coli in beef cattle
Date:2/27/2008

MANHATTAN, KAN. -- Despite millions of dollars spent on food safety research over the last 10 years, ground beef recalls due to E. coli O157:H7 were higher in 2007 than in 2006, according to researchers from Kansas State University and West Texas A&M University. E. coli O157:H7 has been linked to foodborne illnesses in humans after consuming contaminated beef and produce.

"We have been studying the effects of a novel vaccine technology to make beef safer," said Dr. Dan Thomson, an associate professor at Kansas State University.

Thomson worked with Dr. Guy Loneragan, West Texas A&M University, and Dr. T.G. Nagaraja, of K-State, to examine the effects of this vaccine on its ability to decrease E. coli shedding in beef cattle.

"We had a decrease in cattle shedding E. coli by 54 percent in our first field study," Thomson said. "However, we increased the amount of SRP exposure in the second field study and decreased the rate of cattle shedding E. coli by 85 percent."

Loneragan said, "This tells us that efficacious interventions that predictably reduce the burden of E. coli O157 on cattle entering packing plants are needed. Successful interventions will reduce the burden of E. coli O157 to a level that is within the capacity of in-plant interventions to handle. If this can be achieved, then tremendous progress toward preventing E. coli O157 from ever getting into ground beef has been made. This vaccine appears to fit this purpose and has great promise."

The team's findings will be presented at the 2008 Beef Industry Safety Summit in Dallas March 5.

Thomson and his colleagues studied Siderophore receptor and porin -- SRP -- technology, which was developed by Epitopix, LLC in Willmar, Minn.

"Siderophore receptor and porin proteins are utilized by food borne pathogens like E. coli to acquire iron," Thomson said. "The SRP vaccine technology immunizes animals against these mechanisms and does not allow the bacteria to take up iron. Iron is to bacteria, as oxygen is to humans. Without iron consumption, the bacteria suffocate and can't grow or replicate."

"We conducted a challenge study, a natural infection study and two large pen field studies at commercial feedyards," Thomson said. "All studies showed positive results of this vaccine, making an impact on decreasing not only the number of the cattle shedding the bacteria but also decreasing the concentration of the bacteria being shed."

Super shedder cattle are cattle that shed E. coli in very high concentrations. "Our natural field study showed that the SRP technology vaccine reduces the number of super shedder cattle," Thomson said.

The two large pen feeding studies the team conducted utilized 20 pens and more than 1,200 head of cattle, Thomson said. The first study conducted in 2006 was funded in part by beef and veal producers and importers through their $1-per-head checkoff and was produced for the Cattlemen's Beef Board and state beef councils by the National Cattlemen's Beef Association. The second study was sponsored by Epitopix, LLC in 2007.


'/>"/>

Contact: Dan Thomson, DVM, Ph.D.
dthomson@vet.k-state.edu
785-532-4254
Kansas State University
Source:Eurekalert

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
4. Bipolar disorder relapses halved by Melbourne researchers
5. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
6. High and mighty: first common height gene identified by researchers behind obesity gene finding
7. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
8. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
9. Researchers develop long-lasting growth hormone
10. Jefferson immunology researchers halt lethal rabies infection in brain
11. Purdue researchers develop technology to detect cancer by scanning surface veins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ... 2017 , ... The non-profit Seafood Nutrition Partnership (SNP) ... the Science Symposium in partnership with the Global Organization for EPA and DHA ... a forum for global leaders in human nutrition to outline the latest consensus ...
(Date:8/22/2017)... ... August 22, 2017 , ... Western North ... at a popular international aesthetics conference for medical professionals about the positive impact ... health and his growing practice. , Dr. George K. Ibrahim shared ...
(Date:8/22/2017)... ... 22, 2017 , ... Nurses at Apple Rehab Watch Hill , a ... training and certification in Closed Pulse Irrigation™ (CPI) for wound care. This ... the Centers for Medicare and Medicaid Services, to have a CPI machine that will ...
(Date:8/22/2017)... , ... August 22, 2017 , ... ... story of child abuse and neglect, and the struggles faced while hoping for ... the creation of published author, Judy Von Bernewitz, who spent 13 years working ...
(Date:8/22/2017)... ... August 22, 2017 , ... TopConsumerReviews.com recently gave a best-in-class 5-star rating ... , As the stress of modern life continually makes more demands on time and ... artificial stimulants can trap people in vicious high/low cycles and can also cause long ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... , Aug. 15, 2017  AOTI Inc. announced today that its ... Inc., has recently opened a New York City Office in ... of its unique Topical Wound Oxygen (TWO 2 ) homecare therapy. ... Accreditation Commission for Health Care (ACHC) under the company,s DMEPOS accreditation ... ...
(Date:8/11/2017)... -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... today announced that it will release its second quarter ... conference call at 9:00am ET. The Company will discuss ... its strategy and outlook for the remainder of 2017. The ... , Chief Executive Officer, and Zvi Ben-David , ...
(Date:8/8/2017)... TEL AVIV, Israel, Aug. 8, 2017  BioLineRx Ltd. ... and immunology, today reports its financial results for the ... and achievements during the second quarter 2017 and to ... on multiple clinical development programs for the Company,s lead ... Phase 3 pivotal study with BL-8040 as novel stem ...
Breaking Medicine Technology: